GENEIII Sets the Global Benchmark for Ergothioneine with Pharmaceutical-Grade Purity and Human Clinical Validation

SINGAPORE, Jan. 20, 2026 /PRNewswire/ — On January 9th, GENEIII reaffirmed its global…

FITUR 2026 brings together global tourism with more than 160 countries and 10,000 companies

Mexico joins FITUR 2026 as Partner Country in an edition bringing together…

ZTO Express Holds 2026 National Network Conference

SHANGHAI, Jan. 20, 2026 /PRNewswire/ — On January 20, 2026, ZTO Express (Cayman)…

Bybit Explores 2026 Macro Volatility and Always-On Market Access

DUBAI, UAE, Jan. 20, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency…

Building the Run: Xtep Charts a New Community Ecosystem in Southeast Asia

JAKARTA, Indonesia and KUALA LUMPUR, Malaysia, Jan. 20, 2026 /PRNewswire/ — Global performance…

Multilingual AI Voice Agent was launched by Zadarma

LONDON, Jan. 20, 2026 /PRNewswire/ — Zadarma, a global VoIP service provider,…

AI/works™ heralds a new era of Agile and next-generation software development

Thoughtworks’ agentic development platform developed to support both technology modernization and greenfield…

Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development

– In head-to-head non-human primate (NHP) studies, average observed half-life of ASC37…